GSK Consent Decree Sets “Aggressive” 150-Day Timeline For GMP Conformity
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline's consent decree mandates that the company notify the agency within 150 days of the corrective measures it has taken or plans to take in addressing FDA's good manufacturing practice concerns